Optimising treatment with tumour necrosis factor inhibitors in rheumatoid arthritis: is dose tapering practical in good responders? A 'proof of principle' and exploratory trial (OPTTIRA)

Kingsley, Gabrielle (Primary Investigator)
Scott, David (Primary Investigator)
Choy, Ernest (Co-Investigator)
Cope, Andrew (Co-Investigator)

Inflammation Biology

Project: Research

Status	Finished
Effective start/end date	1/04/2009 → 30/09/2014

Collaborative partners

King's College London (lead)
MRC Clinical Trials Unit
National Rheumatoid Arthritis Society
Crescendo Bioscience

Funding

Arthritis Research UK: £436,823.00